What if we can stop Alzheimer’s before it starts?
What if we can stop Alzheimer’s before it starts?
A future where Alzheimer’s can be prevented isn’t just possible – it’s probable.
After decades of research and the bravery of families around the world, a series of clinical trials have discovered when biomarkers of Alzheimer’s begin and have also unlocked ways to delay the onset of the disease.
The Dominantly Inherited Alzheimer Network (DIAN), led by WashU Medicine, follows families who carry rare genetic mutations that cause early-onset Alzheimer’s, revealing the earliest change in the brain and helping us transform inherited risk into the promise of prevention.
In Our Lifetime
In Our Lifetime, a new video series from WashU Medicine, explores the research through the eyes of four different participants, and the hope it provides to millions around the world.
Part 1: A Piece of Me
Jake Heinrichs had to watch his father and brother succumb to early-onset Alzheimer’s. And while he carries the same gene, he is still asymptomatic at 51 — the same age his father was when he passed. Watch as he shares his story of nearly 15 years of participating in clinical trials and the opportunity he never thought he’d have.
Part 2: The World is Watching
Randall J. Bateman, MD, has dedicated his career to researching Alzheimer’s disease in search of ways to detect it sooner and fight it harder. Watch to learn why the world is looking to WashU Medicine for answers, the research that is on the verge of finding a cure and what is at risk if we stop now.
CBS News Sunday Morning: Promising clinical trials in Alzheimer’s prevention
In this national spotlight, CBS News chief medical correspondent Dr. Jonathan LaPook explores the groundbreaking global clinical trials lead by Dr. Randall J. Bateman, MD, that are redefining the future of Alzheimer’s care — proving that continued research matters now more than ever.
The climb to find a cure for Alzheimer’s
After more than 17 years of progress, we’re closer than ever to stopping Alzheimer’s disease before it starts. The climb is steep, but prevention trials are getting us closer – and with continued support, the summit is within reach.
TK Neurosciences
TK Copy about neuroscience impact
660 S. Euclid Ave.
St. Louis, MO 63110-1010